Search results
Results from the Tech24 Deals Content Network
The Susan G. Komen 3-Day, frequently referred to as the 3-Day, is a 60-mile walk to raise funds for Susan G. Komen for the Cure and promote awareness to fight breast cancer. Individual participants must raise at least $2,300 to walk 60 miles (96 km) over a three-day weekend. As of 2013, the events are held in seven US cities.
Victoria's Secret is an American lingerie, clothing, and beauty retailer. Founded in 1977 by Roy and Gaye Raymond, [6] [7] the company's five lingerie stores were sold to Les Wexner in 1982. [8] Wexner rapidly expanded into American shopping malls, growing the company into 350 stores nationally with sales of $1 billion by the early 1990s, when ...
Y-ME National Breast Cancer Organization or Y-ME (previously Breast Cancer Network of Strength ), [1] was a Chicago -based national nonprofit organization that provided resources, information, and support to those suffering from breast cancer. Their mission was to "ensure, through information, empowerment and peer support, that no one faces ...
Breast cancer is the most prevalent cancer affecting women of every ethnic group in the United States. Breast cancer incidence among Black women aged 45 and older is higher than that of white women in the same age group. White women aged 60–84 have higher incidence rates of breast cancer than Black women.
1896 – French Dr. Victor Despeignes, "the father of radiation therapy", starts to use X-rays to treat cancer [8] 1896 – American Dr. Emil Grubbe starts to treat breast cancer patients with X-rays [4] 1896 Sir George Thomas Beatson invented hormonal treatment of breast cancer by bilateral ovary removal in women with inoperable breast cancer.
On June 12, 1977, [2] Victoria's Secret was founded by Roy and Gaye Raymond [6] in Delaware. [7] Raymond opened the first Victoria's Secret store at the Stanford Shopping Center in Palo Alto, California. [8] Raymond was inspired to start Victoria's Secret after feeling embarrassed purchasing lingerie for his wife in a department store.
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.
Stage 0 is a pre-cancerous or marker condition, either ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS). Stages 1–3 are within the breast or regional lymph nodes. Stage 4 is a metastatic cancer. Metastatic breast cancer has a less favorable prognosis. Receptor status.